PJMHS 2022
DOI: 10.53350/pjmhs2216265
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D Supplementation reduces Atorvastatin induced Myopathy in Dyslipedemic patients

Abstract: Background: Dyslipidemia is becoming one of the most common problems worldwide predisposing towards atherosclerotic cardiovascular events and other issues like obesity. Statins are imperative for treating dyslipidemia. However statin-intolerance is a major hurdle due to the myopathy incurred with their usage, ranging from mild aches and pains without CPK elevation to marked increase in CPK levels with myonecrosis and even death in rare cases. Aim: Local identification of dyslipedemic patients with reduced vit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…7 Oral vitamin D supplementation can improve insulin resistance in type 2 diabetic patients 8 and could reduce myalgia in patients on statin therapy. 9,10…”
Section: Introductionmentioning
confidence: 99%
“…7 Oral vitamin D supplementation can improve insulin resistance in type 2 diabetic patients 8 and could reduce myalgia in patients on statin therapy. 9,10…”
Section: Introductionmentioning
confidence: 99%